Last reviewed · How we verify
NCT06252051
Effectiveness of Trivalent Influenza Vaccine (TIV) in Type 2 Diabetes Mellitus (T2DM) Patients With and Without Complications of Chronic Kidney Disease (CKD)
Phase 4 trial testing Trivalent Influenza Vaccine in Influenza in 76 participants. Completed in 31 August 2022.
31 March 2022
Quick facts
| Lead sponsor | Universitas Padjadjaran |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 76 |
| Start date | 5 January 2021 |
| Primary completion | 31 March 2022 |
| Estimated completion | 31 August 2022 |
| Sites | 1 location across Indonesia |
Drugs / interventions tested
- Trivalent Influenza Vaccine — full drug profile →
Conditions studied
- Influenza — all drugs for Influenza →
- Vaccine Reaction — all drugs for Vaccine Reaction →
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
- Chronic Kidney Diseases — all drugs for Chronic Kidney Diseases →
Sponsor
Universitas Padjadjaran — full company profile →
Who can join
Adults 40 to 49, any sex, with Influenza or Vaccine Reaction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study assesses the effectiveness of the seasonal flu vaccine in individuals with Type 2 Diabetes Mellitus (T2DM) with and without Chronic Kidney Disease (CKD), as well as in healthy individuals. Additionally, the study investigates the dynamics of cytokines, specifically IL-2 and IL-6, in the three groups following influenza vaccination. The findings from these studies will contribute to our understanding of the safety and efficacy of the influenza vaccine in T2DM and T2DM-CKD, shedding light on inflammation changes and informing future research on mitigation strategies.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Immunogenicity, Safety, and Efficacy of Influenza Vaccine in T2DM and T2DM with Chronic Kidney Disease.
Heryaman H, Juli C, Nazir A, Syamsunarno MRAA, et al · · 2024 · cited 1× · PMID 38543861 · DOI 10.3390/vaccines12030227
Verify or expand the search:
- PubMed search for NCT06252051
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Trivalent Influenza Vaccine
Trials testing the same drug.
- NCT04080531 — Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders · Phase 4 · completed
- NCT03336593 — Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian Population · Phase 2 · completed
- NCT04484532 — Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receivin · EARLY_PHASE1 · completed
- NCT03179761 — High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients · Phase 2 · completed
- NCT02518555 — Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leuke · Phase 2 · completed
Other recruiting trials for Influenza
Currently open trials in the same condition.
- NCT07215858 — BPL-1357 Against H1N1 Influenza Virus Challenge · Phase 2 · recruiting
- NCT07496450 — A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults · Phase 3 · recruiting
- NCT07302256 — A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above · Phase 1 · recruiting
- NCT07431840 — Immune Defense Protein Impact On Respiratory Immune Outcomes · NA · recruiting
- NCT07485855 — Influenza Vaccination Strategy for Patients With Hematologic Malignancy · Phase 3 · recruiting
Other Universitas Padjadjaran trials
Trials by the same sponsor.
- NCT07506486 — Effect of Immersive Virtual Reality Cognitive Rehabilitation on Subacute Stroke Patients (A Pilot Study) · NA · not yet recruiting
- NCT07494357 — Effects of Dual Task-Oriented Circuit Training on Walking Recovery in Sub-acute Stroke · NA · not yet recruiting
- NCT07451899 — TB Type and Spirometry Result vs. Functional Capacity Based on 6MWT in People With Post-TB Lung Disease · not yet recruiting
- NCT07467954 — Comparative Effectiveness of Long-Pulsed 1064-nm Nd:YAG and Fractional CO₂ Laser in Skin Rejuvenation · NA · recruiting
- NCT07344688 — The Effect of White Tea in Healthy Human Subjects · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06252051 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitas Padjadjaran
- Last refreshed: 9 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06252051.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing